• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Solexa

edit

Solexa engages in developing and commercializing genetic analysis technologies primarily in the United States and the United Kingdom. The company is developing and preparing Solexa Genome Analysis System, which performs DNA sequencing based on its proprietary reversible terminator Sequencing-by-Synthesis, chemistry, and Clonal Single Molecule Array technology. Its platform is designed to support a range of analyses, including whole genome resequencing, gene expression analysis, and small RNA analysis.

Recent Milestones

edit

• 
  Solexa received $75M in Venture Round funding. (9/20/06)
  Posted 4/19/10 at 7:38pm via bizjournals.com
• 
  Solexa received $65M in Venture Round funding. (11/21/05)
  Posted 7/1/10 at 3:18am via businesswire.com
• 
  Solexa received $32.5M in Venture Round funding. (4/22/05)
  Posted 7/1/10 at 5:25am via allbusiness.com

Videos

Screenshots

edit

Sources

1. Solexa Announces Agreement for $32.5 Million Private Equity Financing (allbusiness.com) [edit]
2. Solexa Announces Agreement for $65 Million Private Placement (businesswire.com) [edit]
3. Solexa gets $75M equity financing commitment (eastbay.bizjournals.com) [edit]